Axa S.A. Arcutis Biotherapeutics, Inc. Transaction History

Axa S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $46,284 - $92,445	6,163 Added 1.39%	448,642 $4.28 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $1.09 Million - $1.83 Million	106,693 Added 31.77%	442,479 $4.87 Million
Q4 2022 Feb 14, 2023	SELL	$13.96 - $20.4 $25,253 - $36,903	-1,809 Reduced 0.54%	335,786 $4.97 Million
Q3 2022 Feb 14, 2023	BUY	$17.85 - $26.95 $2.03 Million - $3.07 Million	113,963 Added 50.96%	337,595 $6.45 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $2.03 Million - $3.07 Million	113,963 Added 50.96%	337,595 $6.45 Million
Q2 2022 Feb 14, 2023	SELL	$16.33 - $22.2 $2.14 Million - $2.92 Million	-131,311 Reduced 36.99%	223,632 $4.77 Million
Q2 2022 Aug 15, 2022	SELL	$16.33 - $22.2 $2.14 Million - $2.92 Million	-131,311 Reduced 36.99%	223,632 $4.77 Million
Q1 2022 Feb 14, 2023	BUY	$14.38 - $22.79 $249,464 - $395,360	17,348 Added 5.14%	354,943 $6.84 Million
Q1 2022 May 13, 2022	BUY	$14.38 - $22.79 $843,962 - $1.34 Million	58,690 Added 19.81%	354,943 $6.84 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $556,791 - $947,809	37,169 Added 14.35%	296,253 $6.14 Million
Q3 2021 Nov 15, 2021	BUY	$19.28 - $27.1 $303,081 - $426,012	15,720 Added 6.46%	259,084 $6.19 Million
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $459,486 - $653,856	18,816 Added 8.38%	243,364 $6.64 Million
Q1 2021 May 14, 2021	BUY	$24.47 - $36.98 $5.49 Million - $8.3 Million	224,548 New	224,548 $6.5 Million

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.